quin2 has been researched along with 4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gabbay, RA; Lardy, HA | 1 |
1 other study(ies) available for quin2 and 4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone
Article | Year |
---|---|
Methylisobutylxanthine blocks insulin antagonism of cAMP-stimulated glycogenolysis at a site distinct from phosphodiesterase. Evidence favoring an insulin-insensitive calcium release mechanism.
Topics: 1-Methyl-3-isobutylxanthine; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; 8-Bromo Cyclic Adenosine Monophosphate; Aminoquinolines; Animals; Calcium; Concanavalin A; Cyclic AMP; Glucose; Insulin; Lactates; Lactic Acid; Liver Glycogen; Male; Phenylephrine; Phenylisopropyladenosine; Phosphodiesterase Inhibitors; Rats; Rats, Inbred Strains; Theophylline; Vasopressins | 1986 |